ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,762 | +25.9% | 2,444 | +52.3% | 0.00% | 0.0% |
| Q2 2023 | $21,250 | -2.7% | 1,605 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $21,844 | -35.3% | 1,605 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $33,753 | +12.5% | 1,605 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $30,000 | -9.1% | 1,605 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | -36.5% | 1,605 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $52,000 | -30.7% | 1,605 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $75,000 | +74.4% | 1,605 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $43,000 | +4.9% | 1,605 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $41,000 | -25.5% | 1,605 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $55,000 | +77.4% | 1,605 | +76.2% | 0.00% | +100.0% |
| Q4 2020 | $31,000 | +40.9% | 911 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $22,000 | – | 911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |